•    PJI epidemiology and diagnostic criteria for PJI using current evidence-based frameworks 
•    A diagnostic approach for PJI, integrating biomarkers, imaging, and advanced microbiologic techniques, including NGS and sonication.
•    Antimicrobial strategies for PJI management, rifampin-based therapy, and rifabutin as an alternative when DDIs preclude rifampin use.